Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
The 2023-2028 World Outlook for Leukemia Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Lung Cancer Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Genomics in Cancer Care
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Immunotherapy Cancer Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Prostate Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Cancer Specialty Hospitals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Cancer Pain
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Cancer Testing-Screening
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Cancer Supportive Care
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Chronic Lymphocytic Leukemia
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Cancer Diagnostics Laboratory Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Cancer Profiling and Pathways
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Cancer Pain Management
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care
... year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of ... Read More
-
Cryoablation Devices Market, By Device Type (Systems, and Probes), by Application (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Surgical Clinics), and by Regions (North A
... America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cryotherapy and radiofrequency ablation (RFA) are the two clinically viable ablation systems that are widely ... Read More
-
Anal Cancer Market, by Drug Type (Fluorouracil, Cisplatin, Carboplatin, and Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)), by Cancer Type (Carcinoma In-situ, Squamous Cell Carcinoma, Melanoma, Adenocarcinoma, and Basal Cell
... (Chemotherapy, Surgery, Radiation Therapy, and Immunotherapy), by Distribution Channel (Hospitals & Clinics, Research & Academic Institutes, Long-term Care Centers, and Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) ... Read More
-
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
... In 2022, there will be more than 1,490,000 diagnosed prevalent cases of renal cell carcinoma across 16 pharmaceutical markets. There are 10 leading marketed drugs for the treatment of renal cell carcinoma, Merck is a ... Read More
-
Nasal Cannula Market, by Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula) by Material (Plastic, Silicon ) by Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD,
... Emphysema, Cystic fibrosis, and Pneumonia ) by End User (Hospital, Long term care center, Home care settings, Ambulatory surgical centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Anti-Cathepsin B Market, by Product Type (Primary Antibodies, Proteins and Peptides, and Lysates), by Application (Cancer, Traumatic Brain Injury, Ebola Infection, Fertility Treatment, and Others), by Technique (Immunohistochemistry, Immunofluorescence, W
... Others), by End User (Pharmaceutical Companies, and Academic and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 ... Read More
-
Liquid Biopsy Market, By Biomarker Type (CTC (Circulating Tumor Cells), ctNA (Circulating Tumor Nucliec Acids), Exosomes), By Sample Type (Blood, Urine, Others), By Disease Indication (Lung Cancer, Gastrointestinal Cancer, Prostate Cancer, Breast Cancer,
... Leukemia, Others), By End User (Hospitals, Cancer Institutes, Academic Institutes, Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Oncology Information System Market Forecasts to 2028 – Global Analysis By Product & Services Software, Professional Services), Application (Medical Oncology, Radiation Oncology), End User (Government Institutions, Hospitals & Diagnostic Imaging Centers) and By Geography
... to Stratistics MRC, the Global Oncology Information System Market is accounted for $7.46 billion in 2021 and is expected to reach $14.00 billion by 2028 growing at a CAGR of 9.4% during the forecast period. ... Read More
-
Monoclonal Antibodies Market Size By Type (Fully Human, Humanized, Chimeric), By Application (Oncology, Autoimmune Diseases, Infectious Diseases), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
... - 2028 The monoclonal antibodies market would expand at a progressive CAGR through 2028 owing to the rising incidence of infectious, chronic, and rare diseases, including cancer, across the globe. As per the WHO, cancer ... Read More
-
Lung Cancer Diagnostic and Screening Market, by Test Type (Biomarkers Test (EGFR Mutation Test, KRAS Mutation Test, ALK Test, HER2 Test, Others), Imaging Test ( Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Chest X-Ray, Others),
... X-Ray, Others), Biopsy (Needle Biopsy, Bronchoscopy Biopsy, Open Biopsy, Others), By Cancer Type (Non-small cell lung cancer and Small Cell Lung Cancer), by End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer ... Read More
-
Histology and Cytology Market, by Product Type (Instruments and Analysis Software System and Consumable and Reagents), by Examination Type (Histology and Cytology {Breast Cancer, Cervical Cancer, and Others (Others include Oral Cancer, Leukemia, Infectiou
... and Inflammatory Diseases)}), by Test Type (Microscopy Tests (Cytogenic Tests and Polymerase Chain Reaction), Molecular Genetics Tests, and Flow Cytomtery), by End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and by Region ... Read More
-
Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PE
... MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy Immunohistochemistry In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood ... Read More
Research Assistance
